Pibrentasvir-D6

Print | Download pdf
Stock Status : <%stockStatus%>

<%deliveryStatus%>

Catalogue number: PA STI 089201
Chemical name: Pibrentasvir-D6

CAS Number:

NA
Category: stable isotopes,antiviral agents,impurities,metabolites,pharmaceutical standards,intermediates,Fine Chemicals
Synonyms:

Bis(methyl-d3) ((2S,2'S,3R,3'R)-((2S,2'S)-(((2R,5R)-1-(3,5-difluoro-4-(4-(4-fluorophenyl)piperidin-1-yl)phenyl)pyrrolidine-2,5-diyl)bis(5-fluoro-1H-benzo[d]imidazole-6,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methoxy-1-oxobutane-1,2-diyl))dicarbamate;
Molecular form: C57H59D6F5N10O8
Appearance: NA
Mol. Weight: 1119.24
Storage: 2-8°C Refrigerator
Shipping Conditions: Ambient
Applications: Pibrentasvir-D6 is an isotopically labelled analog of Pibrentasvir is an antiviral used for hepatitis C virus NS3/4A protease inhibition.

Pibrentasvir-D6

NA
| Sample COA MSDS

Enquire for Pibrentasvir-D6

I accept terms and conditions

Order Product

Related Products

1332357-14-8

5,5'-[(2R,5R)-1-[3,5-Difluoro-4-[4-(4-fluorophenyl)-1-piperidinyl]phenyl]-2,5-pyrrolidinediyl]bis[6-fluoro-2-(2S)-2-pyrrolidinyl-1H-benzimidazole]
1890114-11-0

(2S,2'S)-2,2'-[[(2R,5R)-1-[3,5-Difluoro-4-[4-(4-fluorophenyl)-1-piperidinyl]phenyl]-2,5-pyrrolidinediyl]bis(6-fluoro-1H-benzimidazole-5,2-diyl)]bis-1-pyrrolidinecarboxylic acid 1,1'-bis(1,1-dimethylethyl) ester
1292836-20-4

(1S,4S)-1,4-Bis(4-chloro-2-fluoro-5-nitrophenyl)butane-1,4-diol
1332356-31-6

3,5-Difluoro-4-[4-(4-fluorophenyl)piperidin-1-yl]aniline
1353900-92-1

Pibrentasvir - API Standards

EVENTS

Search by Keywords – Buy Pibrentasvir-D6 | Purchase Pibrentasvir-D6 | Order Pibrentasvir-D6 | Enquire Pibrentasvir-D6 | Price of Pibrentasvir-D6 | Pibrentasvir-D6 Cost | Pibrentasvir-D6 Supplier | Pibrentasvir-D6 Distributor | Pibrentasvir-D6 Manufacturer | Pibrentasvir-D6 Exporter

Tools

Calculators

Normality Dilution Mass molarity
Periodic Table- Pharmaffiliates

Periodic Table

Ask A Scientist-Pharmaffiliates

Ask a Scientist
General Help

General Help

cart bucket

×
Proceed

wishlist

×
Proceed